1 not yet recruiting, 1 terminated. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Not yet recruiting 1, Terminated 1 |
Follow Hemangioma, Cavernous: new trials by email Literature Review of Hemangioma, Cavernous trials Research Report on Hemangioma, Cavernous
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Daratumumab for Familial Cerebral Cavernous Malformations: A Single-Arm Safety and Efficacy Study Daratumumab - Cavernous Malformation, Cerebral | Early Phase 1 | Not yet recruiting | Beijing Tiantan Hospital | 10 | 2025-07-01 | 2025-06-18 |
| Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins Simvastatin - Cavernous Angioma, Familial, Cerebral Cavernous Malformations | Early Phase 1 | Terminated | University of New Mexico | 12 | 2012-03-01 | 2024-03-12 |
Hemangioma, Cavernous, Central Nervous System (2)
Brain Diseases (2) · Cardiovascular Abnormalities (2) · Cardiovascular Diseases (2) · Cavernous Sinus Syndromes (2) · Central Nervous System Diseases (2) · Central Nervous System Vascular Malformations (2) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Hemangioma (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Hemorrhagic Disorders (2) · Hemostatic Disorders (2) · Neoplasms (2)
Simvastatin (1) · daratumumab (1)
Beijing Tiantan Hospital (1) · University of New Mexico (1)
China (1) · United States (1)
Blaine Hart, MD (1) · Leslie A Morrison, MD (1)
U54NS065705 (1)